Net earnings per share (EPS TTM): DBV Technologies SA (DBVT)

Official company branding of DBV Tech (DBVT)

DBV Technologies S.A. (DBVT) develops painless Viaskin patches to combat food allergies. This annual net income per share chart visualizes the potential of this segment. Management is persistently overcoming regulatory barriers by implementing safe therapy. However, FDA delays and liquidity shortage risks pose a threat to capital. The current -3.05 metric determines this level of issuer yield.

DBVT DBV Technologies SA Earnings per share for the last 12 months (07/04/2022 - 11/12/2026)

DBV Tech - analytical breakdowns and key metrics (DBVT)

- current quotes and average value forecast:
Price Chart DBV Technologies SA|DBVT - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Capitalization DBV Technologies S.A.|DBVT - Company Buyout Price
- business book valuation details:
Net Assets per Single Share DBV Technologies|DBVT - Accounting Capitalization|Market Capitalization to Book Value Ratio dbv-technologies.com|DBVT - Total Business Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital DBV Technologies S.A.|DBVT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio DBV Technologies SA|DBVT - Company Debts|Debt to Book Value DBV Technologies S.A.|DBVT - Company Long-Term Loans and Borrowings|Company Current Liabilities DBV Technologies|Quick Ratio dbv-technologies.com
- earnings and multiples data:
DBVT - Company Net Income|Projected Future Earnings DBV Technologies S.A.|DBVT - Price to Earnings Ratio|Forward P/E Multiple DBV Technologies SA|DBVT - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DBV Technologies S.A.|DBVT - Operating profit before amortization|Earnings per share for the last twelve months DBV Technologies|DBVT - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months dbv-technologies.com|DBVT - Earnings per share growth in current year|Net earnings per share growth forecast for next year DBV Technologies S.A.
Fundamental company valuation:dbv-technologies.com - DBVT
Manufactured products of DBV Technologies S.A.

The technological barrier of DBV Technologies S.A. (DBVT) is based on epicutaneous therapy patents, where commercial success depends directly on regulatory approvals. The annual net income per share trend reflects the actual earnings per share for the year, allowing investors to use this chart to identify a fundamental business slowdown or the risk of overpaying for the asset.

Competing companies

KRYS - Earnings per share for the last twelve months|APGE - Net earnings per share (EPS TTM)|ARQT: Net earnings per share (EPS TTM)|VCEL - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Oruka Corp|Earnings per share for the last 12 months SMTI (Sanara)|Net earnings per share (EPS TTM) SLSN|journeymedicalcorp.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) FBRX (Forte Biosciences)|Empro Group Inc. - Earnings per share for the last twelve months|SLGL: Net earnings per share for the last 12 months|AXIL: Earnings per share for the last twelve months|MDCX (Medicus Pharma Ltd.) - Net earnings per share for the last 12 months|Verrica Pharmaceuticals Inc. - Earnings per share for the trailing year|Net earnings per share for the last 12 months HOTH|BFRI (Biofrontera Inc) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) VYNE|SNOA - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) QNRX (Quoin Pharmaceuticals Ltd.)|AZTR - Net earnings per share for the last 12 months|Dermata Therapeutics, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ELAB (Elevai Labs Inc)|Revance Therapeutics, Inc (RVNC) - Earnings per share for the last twelve months